RocSite Real Estate
Real Estate Agent
Why pick this one
RocSite provides on-premises intracranial hemorrhage triage with no PHI transmission and an FDA Pre-Submission accepted in January 2026.
Best for
- Trauma ICU, neuro-ICU, and emergency-medicine teams evaluating offline intracranial hemorrhage triage
- Hospitals seeking on-premises head CT analysis without transmitting PHI
- FDA-track AI vendors needing locked-instrument grades and signed receipts
- Pharmacovigilance teams needing graded safety records
- Organizations needing pre-registered clinical AI validation and published null-result transparency
Look elsewhere if
- Residential or commercial real-estate brokerage needs
- Clinical deployment requiring an already FDA-approved ICH device
- Workflows that require cloud-based PHI processing
Specialties
- intracranial hemorrhage detection from non-contrast head CT
- AI governance for regulated environments
- pharmacovigilance claim grading
- clinical AI validation and falsification testing
- on-premises company-record search and signed answers
What makes them different
- ICH Triage operates on-premises with no PHI transmitted
- ICH Triage FDA Class II SaMD Pre-Submission accepted in January 2026
- ICH Triage reports preliminary validation metrics of 0.9592 AUC-ROC, 92.5% sensitivity, and 85.0% specificity
- The sepsis study was pre-registered before data access and published its null primary result across 286,510 ICU patients
- RocSite states that originals remain on customer machines and answers can be cryptographically signed
- Response time
- Results in milliseconds
Distilled from this business's own website.
Contact & Location
- Address
- 1529 Sykes Rd, Mebane, NC 27302-9623
- Phone
- +19192898492
- Website
- http://RocSite.com/
- support@rocsite.com
Services
- clinical AI software
- AI governance tools
- pharmacovigilance analysis
- medical AI research
- on-premises document and company-record intelligence